Evidence brief · Supplement

Acetyl-L-Carnitine (ALCAR) for Cognition (MCI/aging)

Evidence grade C — Modest

Overall grade
Grade C
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade C — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Cognition (MCI/aging)Evidence grade C

    Modest

    Smallmixed

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Cognition (MCI/aging) (grade C).

The evidence in words

The verdict

For cognition (mci/aging), Acetyl-L-Carnitine (ALCAR) earns evidence grade C (small effect, mixed consistency) — the evidence is limited or mixed. Modest

How it might work

It shuttles fatty acids into mitochondria for energy, donates acetyl groups for acetylcholine synthesis, and has neuroprotective/antioxidant actions.

How to use it

Safety & cautions

Generally safe; can cause GI upset, and, like carnitine, may raise TMAO. Mildly stimulating for some — take earlier in the day.

Bottom line

A legitimate option for diabetic neuropathy and a reasonable adjunct for mood/aging cognition; less compelling as a general nootropic for the young and healthy.

Goes with

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.